Karah Herdman Parschauer Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Karah Herdman Parschauer.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Karah Herdman Parschauer. Karah Herdman Parschauer is a EVP and General Counsel in Ultragenyx Pharmaceutical Inc. ($RARE) and a Director in Evolus, Inc. ($EOLS) and a Director in Arcturus Therapeutics Holdings Inc. ($ARCT).

Address: C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO 94949 CA

Companies in which Karah Herdman Parschauer is an Insider

Arcturus Therapeutics Holdings Inc.

Trading Symbol: ARCT
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karah Herdman Parschauer: Director
Holdings: 0 shares
Latest Transaction: Jun 24 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Evolus, Inc.

Trading Symbol: EOLS
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karah Herdman Parschauer: Director
Holdings: 19,313 shares
Latest Transaction: Feb 09 2021

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 19,313
Shares Sold: 0
Share Difference: +19,313
Value Difference: $0

Ultragenyx Pharmaceutical Inc.

Trading Symbol: RARE
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Karah Herdman Parschauer: EVP and General Counsel
Holdings: 29,997 shares
Current Value: $2,187,081
Latest Transaction: May 10 2021
$RARE Market Capitalization: $2.92B
$RARE Previous Close: $72.91

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 15x
Sell: 28x
Shares Bought: 87,369
Shares Sold: 79,452
Share Difference: +7,917
Value Difference: +$4,358,918

Latest Insider Trading Transactions of Karah Herdman Parschauer

Sentiment: All, ARCT, EOLS, RARE

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
May 10 2021RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS113.6731335,57929,99730.3 K to 30 K (-1.03 %)
Mar 03 2021RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Option ExerciseA142.4711,0001,567,17011,000
Mar 03 2021RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...SellS138.173,970548,53530,22734.2 K to 30.2 K (-11.61 %)
Mar 03 2021RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...GrantA0.004,636034,19729.6 K to 34.2 K (+15.68 %)
Mar 03 2021RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...GrantA0.005,500029,56124.1 K to 29.6 K (+22.86 %)
Feb 09 2021EOLSEvolus, Inc.Parschauer Karah HerdmanDirectorGrantA0.0019,313019,3130 to 19.3 K
Nov 02 2020RAREUltragenyx Pharmac ...Parschauer Karah HerdmanEVP and General Cou ...Option ExerciseM54.509,903539,71425,000

View all Karah Herdman Parschauer insider transactions.